Silver Book Fact

The initiation of insulin therapy in the management of type 2 diabetes involves an approximate 10% increase in total health care expenditures initially, although this is offset by the consistent and substantial 40% decrease in subsequent total health care expenditures 9 months following insulin initiation.

Rosenblum M, Kane M. Analysis of Cost and Utilization of Health Care Services Before and After Initiation of Insulin Therapy in Patients with Type 2 Diabetes Mellitus. J Managed Care Pharm. 2003; 9(4): 309-16. https://www.jmcp.org/doi/pdf/10.18553/jmcp.2003.9.4.309

Reference

Title
Analysis of Cost and Utilization of Health Care Services Before and After Initiation of Insulin Therapy in Patients with Type 2 Diabetes Mellitus
Publication
J Managed Care Pharm
Publication Date
2003
Authors
Rosenblum M, Kane M
Volume & Issue
Volume 9, Issue 4
Pages
309-16
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Every additional dollar spent on the overall treatment of type 2 diabetes has produced health gains valued at $1.49.  
  • Blood pressure control in diabetics reduces the risk of cardiovascular disease by 33% to 50%, and the risk of microvascular complications by approximately 33%.  
  • Laser Treatment for DR
    Laser treatment of PDR can reduce the 5-year risk of blindness by 90%, and the risk of visual loss from DME by 50%.  
  • Average direct medical costs over time, in 2001, for 194 participants in a community-based pharmaceutical care services program for patients with diabetes.  
  • DR Treatment Reduced Risk of Blindness
    Appropriate treatment can reduce the risk of blindness or moderate vision loss from DR by more than 90%.